The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in the latest of a series of mergers, acquisitions, and stock market launches taking over the diagnostics market.
Hologic’s move is the latest in a flurry of activity from the women’s health specialist, which has snapped up Diagenode in Belgium, Biotheranostics in the US, and Somatex in Germany this year alone.
This is just one example of the many financial transactions happening in the diagnostics market over the past few months, with major deals, increasing stock prices, and unprecedented revenues.
Cancer diagnostics such as liquid biopsies have seen a particular surge in interest, with the US sequencing giant Illumina’s €6.6B acquisition of the California-based liquid biopsy firm Grail last year and the completion of a €1.8B acquisition of US-based firm Thrive Earlier Detection Corp. by Exact Sciences Corp.
“We expect this trend to continue if not to intensify,” said Christian Hense, COO of the Spanish in-vitro diagnostics company Universal Diagnostics,
The post Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions appeared first on Labiotech.eu.
Published on Tue, 20 Apr 2021 08:04:36 +0000 and brought to you by salesforce subtract minutes